Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Inhibition of MurA enzyme from Escherichia coli and Staphylococcus aureus by diterpenes from Lepechinia meyenii and their synthetic analogs
ID
Funes Chabán, Macarena
(
Author
),
ID
Hrast, Martina
(
Author
),
ID
Frlan, Rok
(
Author
),
ID
Graikioti, Dafni G.
(
Author
),
ID
Athanassopoulos, Constantinos M.
(
Author
),
ID
Carpinella, María Cecilia
(
Author
)
PDF - Presentation file,
Download
(2,12 MB)
MD5: 6114EBDD4722452FA78F6E2087879C32
URL - Source URL, Visit
https://www.mdpi.com/2079-6382/10/12/1535
Image galllery
Abstract
Enzymes MurA and MurF, involved in bacterial cell wall synthesis, have been validated as targets for the discovery of novel antibiotics. A panel of plant-origin antibacterial diterpenes and synthetic analogs derived therefrom were investigated for their inhibitory properties on these enzymes from Escherichia coli and Staphylococcus aureus. Six compounds were proven to be effective for inhibiting MurA from both bacteria, with IC$_{50}$ values ranging from 1.1 to 25.1 µM. To further mechanistically investigate the nature of binding and to explain the activity, these compounds were docked into the active site of MurA from E. coli. The aromatic ring of the active compounds showed a T-shaped π–π interaction with the phenyl ring of Phe328, and at least one hydrogen bond was formed between the hydroxy groups and Arg120 and/or Arg91. The results disclosed here establish new chemical scaffolds for the development of novel entities targeting MurA as potential antibiotics to combat the threat of pathogenic bacteria, particularly resistant strains.
Language:
English
Keywords:
dehydroabietane derivatives
,
diterpenes
,
MurA inhibitors
,
MurF inhibitors
,
Staphylococcus aureus MurA
,
Escherichia coli MurA
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2021
Number of pages:
15 str.
Numbering:
Vol. 10, iss. 12, art. 1535
PID:
20.500.12556/RUL-136941
UDC:
543.645.7:615.3
ISSN on article:
2079-6382
DOI:
10.3390/antibiotics10121535
COBISS.SI-ID:
98673411
Publication date in RUL:
25.05.2022
Views:
861
Downloads:
115
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Antibiotics
Shortened title:
Antibiotics
Publisher:
MDPI
ISSN:
2079-6382
COBISS.SI-ID:
522975769
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
15.12.2021
Secondary language
Language:
Slovenian
Keywords:
derivati dehidroabietana
,
diterpeni
,
zaviralci MurA
,
zaviralci MurF
,
bakterijske celice
,
protibakterijsko delovanje
,
odporni sevi
,
antibiotiki
Projects
Funder:
Other - Other funder or multiple funders
Funding programme:
Catholic University of Córdoba
Funder:
Other - Other funder or multiple funders
Funding programme:
CONICET, PIP
Funder:
Other - Other funder or multiple funders
Funding programme:
FONCyT
Project number:
PICT 2017-1381
Funder:
Other - Other funder or multiple funders
Funding programme:
FONCyT
Project number:
PICT 2019-2019-00721
Funder:
Other - Other funder or multiple funders
Funding programme:
University of Patras
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back